All Pharma News
Rexahn Announces Expected Effectiveness of Reverse Stock Split and Merger

Rexahn Announces Expected Effectiveness of Reverse Stock Split and Merger
BIOSPACE
05 Nov 2020
Share Share
Rexahn and Ocuphire Enter into Definitive Merger Agreement

Rexahn and Ocuphire Enter into Definitive Merger Agreement
BIO SPACE
18 Jun 2020
Share Share
Rexahn licenses pancreatic cancer drug candidate in China

Rexahn licenses pancreatic cancer drug candidate in China
Maggie Lynch IN-PHARMATECHNOLOGIST
19 Apr 2019
Share Share
Rexahn & BioSense Enter License Agreement

Rexahn & BioSense Enter License Agreement
GLOBENEWIRE
16 Apr 2019
Share Share
BioXcel Therapeutics Enhances Leadership with Appointment of Vikas Sharma

BioXcel Therapeutics Enhances Leadership with Appointment of Vikas Sharma
NASDAQ
31 Jul 2018
Share Share
Global Renal Cell Cacinoma Drugs Market Overview 2018- Rexahn Bionomics,Cerulean

Global Renal Cell Cacinoma Drugs Market Overview 2018- Rexahn Bionomics,Cerulean
TRUEINDUSTRY
29 Jul 2018
Share Share
Pluristem, Rexahn, Are Biotech Winners, B Riley FBR Says In Bullish Initiation

Pluristem, Rexahn, Are Biotech Winners, B Riley FBR Says In Bullish Initiation
Elizabeth Balboa BENZINGA
15 Jul 2018
Share Share
Rexahn Ph2a Combination Study of RX-3117 and Abraxane®

Rexahn Ph2a Combination Study of RX-3117 and Abraxane®
GLOBENEWSWIRE
15 May 2018
Share Share
Rexahn Pharmaceuticals to Present at Two Upcoming Conferences

Rexahn Pharmaceuticals to Present at Two Upcoming Conferences
PRESS RELEASE
13 Mar 2018
Share Share
Rexahn Reports Data from the Ongoing Phase 2a Clinical Trial of RX-3117

Rexahn Reports Data from the Ongoing Phase 2a Clinical Trial of RX-3117
PRESS RELEASE
12 Feb 2018
Share Share